<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In view of the high incidence of macrovascular diseases in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, the study evaluates the association of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> with fasting plasma Apo B48 levels, a marker of the residual presence of intestinally derived TRLs <z:chebi fb="2" ids="6495">lipoproteins</z:chebi>, thought to be highly atherogenic </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 50 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> aged 35-75 years </plain></SENT>
<SENT sid="2" pm="."><plain>Exclusion criteria were overt macrovascular disease, overt <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (Glomerular filtration rate (GFR) &lt;45 ml/min/1.73 m(2)), or use of <z:chebi fb="0" ids="35679">hypolipidemic agents</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Anthropometry, fasting plasma <z:chebi fb="23" ids="18059">lipids</z:chebi>, plasma <z:chebi fb="0" ids="16737">creatinine</z:chebi>, and HbA1c were measured </plain></SENT>
<SENT sid="4" pm="."><plain>Urinary albumin excretion was measured on a morning urine sample with the ELISA and expressed as albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio </plain></SENT>
<SENT sid="5" pm="."><plain>GFR was estimated using the MDRD formula </plain></SENT>
<SENT sid="6" pm="."><plain>The plasma fasting Apo B48 was measured by ELISA </plain></SENT>
<SENT sid="7" pm="."><plain>Age, gender distribution, fasting plasma <z:chebi fb="23" ids="18059">lipids</z:chebi>, HbA1c, smoking status, plasma <z:chebi fb="0" ids="16737">creatinine</z:chebi>, estimate GFR, and the proportion of patients treated with insulin or <z:chebi fb="0" ids="35674">antihypertensive drugs</z:chebi> were similar for patients with or without <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>People with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> had longer <z:mp ids='MP_0002055'>diabetes</z:mp> duration (borderline significance) and significantly higher Apo B48 (1.765 ± 1.379 μg/ml vs. 1.022 ± 0.692 μg/ml, p = 0.01) than those without <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate logistic regression analysis confirmed that fasting Apo B48 levels were significantly associated with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> independent of major confounders measured in the study </plain></SENT>
<SENT sid="10" pm="."><plain>In patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:mp ids='MP_0002959'>microalbuminuria</z:mp> is associated with elevated Apo B48 levels, independent of major confounders; this may partly explain the excess cardiovascular risk of these patients </plain></SENT>
</text></document>